Related Experiment Video
Updated: Dec 8, 2025
05:34
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
1.1K
Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study
Malick M Gibani1,2, Christofer Toumazou3,4, Mohammadreza Sohbati3
1Department of Infectious Disease, Imperial College London, UK.
The Lancet. Microbe
|September 23, 2020
Summary
The CovidNudge test offers rapid, accurate diagnosis of SARS-CoV-2 at the point of care. This sensitive and specific real-time RT-PCR test eliminates the need for laboratory processing, enabling faster clinical decisions.
Area of Science:
- Infectious Diseases
- Diagnostic Technologies
- Molecular Biology
Background:
- Rapid diagnosis of SARS-CoV-2 is crucial for disease control.
- Standard laboratory RT-PCR requires significant infrastructure and time.
- Novel point-of-care tests aim to overcome these limitations.
Purpose of the Study:
- To assess the diagnostic accuracy of the CovidNudge point-of-care real-time RT-PCR test.
- To compare its performance against standard laboratory-based RT-PCR.
- To evaluate its utility without laboratory handling or sample pre-processing.
Main Methods:
- 386 paired nasopharyngeal swab samples were collected from three hospital groups.
- Samples were tested using the CovidNudge platform and standard laboratory RT-PCR.
- Sensitivity and specificity were calculated for the point-of-care test.
Main Results:
- The CovidNudge test demonstrated 94% sensitivity and 100% specificity compared to laboratory testing.
- Performance remained consistent across different patient groups and prevalence levels.
- Amplification of specific SARS-CoV-2 genes (nucleocapsid and envelope) showed high sensitivity.
Conclusions:
- The CovidNudge platform is a sensitive, specific, and rapid point-of-care test for SARS-CoV-2.
- It requires no laboratory handling or sample pre-processing.
- Its implementation can facilitate timely clinical care and testing strategies.
